Results 21 to 30 of about 6,074,292 (203)

Influence of chromium (III), cobalt (II) and their mixtures on cell metabolic activity

open access: yesCurrent Issues in Pharmacy and Medical Sciences, 2021
Chromium (III) and cobalt (II) are necessary elements required for the proper functioning of the organism, but their excess can cause toxic effects. They are the basic components of implants and are also commonly used in medicine as components of dietary
Czarnek Katarzyna, Siwicki Andrzej K.
doaj   +1 more source

Synthesis and Oxidation ofCobalt(II) Pheophytin-α Complex

open access: yesE-Journal of Chemistry, 2011
The mechanism of oxidation of natural pheophytin-a incorporated with cobalt as the central metal ion has been investigated. Natural pheophytin-aextracted from spinach was metallated with cobalt(II) to form the complex, cobalt(II) pheophytin-α [Cophe ...
Ezekiel D. Dikio, David A. Isabirye
doaj   +1 more source

Scientific Opinion on safety and efficacy of cobalt compounds (E3) as feed additives for all animal species: Cobaltous acetate tetrahydrate, basic cobaltous carbonate monohydrate and cobaltous sulphate heptahydrate, based on a dossier submitted by TREAC EEIG [PDF]

open access: yesEFSA Journal, 2012
<p>Cobalt(III) is a component of cobalamin. Its essentiality as trace element results from the capacity of certain animal species to synthesise cobalamin by the gastrointestinal microbiota.
EFSA Panel on Additives and Products or Substances used in Animal Feed
doaj   +1 more source

Allosteric inhibition of cobalt binding to albumin by fatty acids : implications for the detection of myocardial ischemia [PDF]

open access: yes, 2012
The biomarker "ischemia-modified albumin" (IMA), measured by the albumin-cobalt-binding assay (ACB assay), is the only FDA-approved biomarker for early diagnosis of myocardial ischemia.
Peter J. Sadler   +11 more
core   +1 more source

Cobalt-Catalyzed Direct Alkoxylation of Indoles

open access: yes, 2023
Cobalt(II) salt as a non-noble metal catalyst has been widely used in direct C–H bond functionalization in recent years. In this work, we developed a cobalt-catalyzed C–H cleavage and alkoxylation of indoles with alcohols for the rapid construction of 2 ...
Ping Wei   +7 more
core   +1 more source

Modification of natural zeolite for effective removal of Cd(II) from wastewater [PDF]

open access: yesJournal of Water and Environmental Nanotechnology, 2018
In the current research work the Iranian natural zeolite (clinoptililite) was modified with Cobalt Hexacyanoferrate nanopatricles. The natural and Cobalt Hexacyanoferrat modifed zeolites were characterized by FTIR and SEM techniques  and were empolyed as
Taher Yousefi   +4 more
doaj   +1 more source

Bis(5-chloroquinolin-8-olato)-bis(pyridine)-cobalt(II) as new catalytic material

open access: yesScientific Reports, 2022
Nowadays, studies are carried out on the design and synthesis of new catalysts for olefin oligomerization and polymerization, which would contain non-toxic metals and at the same time show high catalytic activities.
Joanna Drzeżdżon   +8 more
doaj   +1 more source

Hydrometallurgical Process to Recover Cobalt from Spent Li-Ion Batteries

open access: yesResources, 2021
The growth of the lithium-ion battery industry requires a secure supply of raw materials and appropriate end-of-life management of batteries. In almost five years, global cobalt consumption has increased by nearly 30%, driven mainly by rechargeable ...
Neila Djoudi   +2 more
doaj   +1 more source

XAFS spectrum of Cobalt(II) oxide

open access: yes
This dataset consists of X-ray absorption fine structure (XAFS) spectra at Co K-edge of Cobalt(II) oxide measured at Photon Factory BL-12C, and is a part of XAFS database (MDR XAFS DB, https://doi.org/10.48505/nims.1447) as a collection of ...
Photon Factory
core   +2 more sources

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy